World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
76
Citations
22790
World Ranking
1901
National Ranking
926

Overview

Luis Martínez-Sobrido is affiliated with the Texas Biomedical Research Institute in the United States and specializes in medical research with a primary focus on infectious diseases. Their work spans several key subfields such as epidemiology, molecular biology, immunology, and animal science and zoology.

Their research topics cover a variety of viral and infectious disease areas including:

  • SARS-CoV-2 and COVID-19 research
  • Influenza virus research studies
  • COVID-19 clinical research studies
  • Viral gastroenteritis research and epidemiology
  • Respiratory viral infections research
  • Animal virus infections studies
  • Virus-based gene therapy research

Among Martínez-Sobrido's frequently published venues are journals and platforms such as:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Virology
  • Viruses
  • Microbiology Spectrum
  • Methods in Molecular Biology

They have contributed to multiple scientific papers, with recent publications including:

  • "Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing", 2020, Nature
  • "SARS-CoV-2 spike E484K mutation reduces antibody neutralisation", 2021, The Lancet Microbe
  • "Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice", 2020, Nature Communications
  • "Structural basis of RNA cap modification by SARS-CoV-2", 2020, Nature Communications
  • "An In Vitro Microneutralization Assay for SARS-CoV-2 Serology and Drug Screening", 2020, Current Protocols in Microbiology

Frequent collaborators in their research include:

  • Chengjin Ye
  • Aitor Nogales
  • Kevin Chiem
  • Jun-Gyu Park
  • Jordi B. Torrelles

In addition to journal articles, Martínez-Sobrido has a book publication titled The Disappearing of Algeria's Hirak, published in 2024 by the Centre National de la Recherche Scientifique.

Best Publications

  • Distinct RIG-I and MDA5 Signaling by RNA Viruses in Innate Immunity

    Yueh Ming Loo;Jamie Fornek;Nanette Crochet;Gagan Bajwa

  • Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing.

    Laura Riva;Shuofeng Yuan;Xin Yin;Laura Martin-Sancho

  • Inhibition of Retinoic Acid-Inducible Gene I-Mediated Induction of Beta Interferon by the NS1 Protein of Influenza A Virus

    Masaki Mibayashi;Luis Martínez-Sobrido;Yueh Ming Loo;Washington B. Cárdenas

  • Severe Acute Respiratory Syndrome Coronavirus Open Reading Frame (ORF) 3b, ORF 6, and Nucleocapsid Proteins Function as Interferon Antagonists

    Sarah A. Kopecky-Bromberg;Luis Martínez-Sobrido;Matthew Frieman;Ralph A. Baric

  • Inhibition of Alpha/Beta Interferon Signaling by the NS4B Protein of Flaviviruses

    Jorge L. Muñoz-Jordán;Maudry Laurent-Rolle;Joseph Ashour;Luis Martínez-Sobrido

  • The Ebola Virus VP35 Protein Inhibits Activation of Interferon Regulatory Factor 3

    Christopher F. Basler;Andrea Mikulasova;Luis Martinez-Sobrido;Jason Paragas

  • Multiple anti-interferon actions of the influenza A virus NS1 protein

    Georg Kochs;Adolfo García-Sastre;Luis Martínez-Sobrido

  • Ebola Virus VP35 Protein Binds Double-Stranded RNA and Inhibits Alpha/Beta Interferon Production Induced by RIG-I Signaling

    Washington B. Cárdenas;Yueh Ming Loo;Michael Gale;Amy L. Hartman

  • The intracellular sites of early replication and budding of SARS-coronavirus

    Silke Stertz;Mike Reichelt;Martin Spiegel;Thomas Kuri

  • Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice.

    Fatai S. Oladunni;Jun-Gyu Park;Paula A. Pino;Olga Gonzalez

  • SARS-CoV-2 spike E484K mutation reduces antibody neutralisation.

    Sonia Jangra;Chengjin Ye;Raveen Rathnasinghe;Daniel Stadlbauer

  • Inhibition of Beta Interferon Induction by Severe Acute Respiratory Syndrome Coronavirus Suggests a Two-Step Model for Activation of Interferon Regulatory Factor 3

    Martin Spiegel;Andreas Pichlmair;Luis Martínez-Sobrido;Jerome Cros

  • Inhibition of the Type I Interferon Response by the Nucleoprotein of the Prototypic Arenavirus Lymphocytic Choriomeningitis Virus

    Luis Martínez-Sobrido;Elina I. Zúñiga;Debralee Rosario;Adolfo García-Sastre

  • Transcriptional role of p53 in interferon-mediated antiviral immunity

    César Muñoz-Fontela;Salvador Macip;Luis Martínez-Sobrido;Lauren Brown

  • Identification of Cellular Interaction Partners of the Influenza Virus Ribonucleoprotein Complex and Polymerase Complex Using Proteomic-Based Approaches

    Daniel Mayer;Kaaweh Molawi;§ Luis Martínez-Sobrido;Alexander Ghanem

  • Replication fitness determines high virulence of influenza A virus in mice carrying functional Mx1 resistance gene

    Daniel Grimm;Peter Staeheli;Martin Hufbauer;Iris Koerner

  • Differential Inhibition of Type I Interferon Induction by Arenavirus Nucleoproteins

    Luis Martínez-Sobrido;Panagiotis Giannakas;Beatrice Cubitt;Adolfo García-Sastre

  • Structural basis of RNA cap modification by SARS-CoV-2.

    Thiruselvam Viswanathan;Shailee Arya;Shailee Arya;Siu Hong Chan;Shan Qi;Shan Qi

  • Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus.

    Adam Vigil;Man Seong Park;Osvaldo Martinez;Mark A. Chua

  • An In Vitro Microneutralization Assay for SARS-CoV-2 Serology and Drug Screening.

    Fatima Amanat;Kris M. White;Lisa Miorin;Shirin Strohmeier

  • Lethality of SARS-CoV-2 infection in K18 human angiotensin converting enzyme 2 transgenic mice

    Fatai S. Oladunni;Jun-Gyu Park;Paula Pino Tamayo;Olga Gonzalez

Frequent Co-Authors

Adolfo García-Sastre
Adolfo García-Sastre Icahn School of Medicine at Mount Sinai
Juan Carlos de la Torre
Juan Carlos de la Torre Scripps Research Institute
David J. Topham
David J. Topham University of Rochester Medical Center
Colin R. Parrish
Colin R. Parrish Cornell University
Tim J. Anderson
Tim J. Anderson Texas Biomedical Research Institute
Daniel R. Perez
Daniel R. Perez University of Georgia
John J. Treanor
John J. Treanor University of Rochester Medical Center
Peter Palese
Peter Palese Icahn School of Medicine at Mount Sinai
Stephen Dewhurst
Stephen Dewhurst University of Rochester
Georg Kochs
Georg Kochs University of Freiburg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in expanding their expertise beyond Immunology, pursuing related online degrees can open diverse career opportunities in healthcare. Many aspiring professionals explore online RN programs for non nurses as a flexible pathway to enter the nursing field without a traditional background. These programs often offer accelerated options tailored for students transitioning from other disciplines.

Accelerated nursing tracks such as absn programs with high acceptance rates appeal to those seeking a fast yet attainable route to a Bachelor of Science in Nursing. This can be an excellent complement to Immunology studies, especially for students aiming to work in clinical settings or research.

For individuals looking to start their nursing career quickly, exploring the easiest LPN programs to get into may offer a practical stepping stone. Licensed Practical Nurse programs provide foundational knowledge relevant to patient care and immunological monitoring.

Finally, those interested in advanced practice roles should consider what is the easiest NP program, which highlights nurse practitioner degrees that are accessible and streamlined. This credential can significantly enhance career prospects by combining clinical expertise with immunological insights.

Best Scientists Citing Luis Martínez-Sobrido

Trending Scientists